119 related articles for article (PubMed ID: 11123716)
1. High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas.
Miettinen HE; Järvinen TA; Kellner U; Kauraniemi P; Parwaresch R; Rantala I; Kalimo H; Paljärvi L; Isola J; Haapasalo H
Neuropathol Appl Neurobiol; 2000 Dec; 26(6):504-12. PubMed ID: 11123716
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of DNA topoisomerase IIalpha expression provides independent prognostic information in non-Hodgkin's lymphomas.
Korkolopoulou P; Angelopoulou M; Siakantari M; Mitropoulos F; Vassilakopoulos T; Zorzos H; Rassidakis G; Androulaki A; Patsouris E; Kittas C; Davaris P; Pangalis GA
Histopathology; 2001 Jan; 38(1):45-53. PubMed ID: 11135046
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
Korshunov A; Golanov A
Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
[TBL] [Abstract][Full Text] [Related]
4. Prognostic potential of topoisomerase IIα and HER2 in a retrospective analysis of early advanced breast cancer patients treated with adjuvant anthracycline chemotherapy.
Biesaga B; Niemiec J; Ziobro M; Wysocka J; Kruczak A
Breast; 2011 Aug; 20(4):338-50. PubMed ID: 21507646
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin A and topoisomerase IIalpha of oligodendrogliomas is correlated with tumour grade, MIB-1 labelling index and survival.
Park SH; Suh YL
Histopathology; 2003 Apr; 42(4):395-402. PubMed ID: 12653952
[TBL] [Abstract][Full Text] [Related]
6. Expression of DNA topoisomerase IIalpha in oligodendroglioma.
Bredel M; Gatterbauer B; Birner P; Haberler C; Ströbel T; Budka H; Rössler K; Hainfellner JA
Anticancer Res; 2002; 22(2B):1301-4. PubMed ID: 12168941
[TBL] [Abstract][Full Text] [Related]
7. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique.
Miettinen HE; Paunu N; Rantala I; Kalimo H; Paljärvi L; Helin H; Haapasalo H
J Neurooncol; 2001 Oct; 55(1):29-37. PubMed ID: 11804280
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
[TBL] [Abstract][Full Text] [Related]
10. BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy.
Biesaga B; Niemiec J; Ziobro M
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2009-19. PubMed ID: 25005788
[TBL] [Abstract][Full Text] [Related]
11. [Expression of topoisomerase IIalpha in nasopharyngeal carcinoma and its clinical significance].
Xiang YQ; Min HQ; Hong MH; Cao SM; He JH; Hou JH; Guo X
Ai Zheng; 2004 Mar; 23(3):322-5. PubMed ID: 15025967
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma.
Doussis-Anagnostopoulou IA; Vassilakopoulos TP; Thymara I; Korkolopoulou P; Angelopoulou MK; Siakantaris MP; Kokoris SI; Dimitriadou EM; Kalpadakis C; Matzouranis M; Kaklamanis L; Panayiotidis P; Kyrtsonis MC; Androulaki A; Patsouris E; Kittas C; Pangalis GA
Clin Cancer Res; 2008 Mar; 14(6):1759-66. PubMed ID: 18347177
[TBL] [Abstract][Full Text] [Related]
13. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H
Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798
[TBL] [Abstract][Full Text] [Related]
14. Mitosin and DNA topoisomerase IIalpha: two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival.
Korkolopoulou P; Patsouris E; Konstantinidou AE; Christodoulou P; Thomas-Tsagli E; Kouzelis K; Angelidakis D; Rologis D; Davaris P
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):207-14. PubMed ID: 11556747
[TBL] [Abstract][Full Text] [Related]
15. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
Järvinen TA; Holli K; Kuukasjärvi T; Isola JJ
Br J Cancer; 1998 Jun; 77(12):2267-73. PubMed ID: 9649144
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 in oligodendroglial neoplasms.
Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
[TBL] [Abstract][Full Text] [Related]
18. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas.
Konstantinidou AE; Patsouris E; Korkolopoulou P; Kavantzas N; Mahera H; Davaris P
Histopathology; 2001 Oct; 39(4):402-8. PubMed ID: 11683942
[TBL] [Abstract][Full Text] [Related]
20. High levels of topoisomerase IIalpha protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment.
Pentheroudakis G; Goussia A; Voulgaris E; Nikolaidis K; Ioannidou E; Papoudou-Bai A; Grepi K; Kanavaros P; Pavlidis N; Bai M
Leuk Lymphoma; 2010 Jul; 51(7):1260-8. PubMed ID: 20497003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]